Ignite Creation Date:
2024-05-06 @ 7:56 PM
Last Modification Date:
2024-10-26 @ 3:16 PM
Study NCT ID:
NCT06183931
Status:
RECRUITING
Last Update Posted:
2024-06-21
First Post:
2023-11-15
Brief Title:
Study of ALXN2220 Versus Placebo in Adults With ATTR-CM
Sponsor:
Alexion Pharmaceuticals Inc
Organization:
Alexion Pharmaceuticals Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-01-11
Start Date Type:
ACTUAL
Primary Completion Date:
2028-07-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-10-31
Completion Date Type:
ESTIMATED
First Submit Date:
2023-11-15
First Submit QC Date:
December 14 2023
Study First Post Date:
2023-12-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-23
Last Update Post Date:
2024-06-21
Last Update Post Date Type:
ACTUAL